Professor Tinglong Dai discusses a current cancer drug shortage that was caused by a deplorable foreign manufacturing facility that stopped exporting chemotherapy drugs to the U.S. after an  inspection that revealed "a cascade of failures." But it could be worse — 4 Americans have died and 8 have been blinded after using generic eyedrops made in a foreign facility that was never inspected by the . In 2022, the  inspected only 6% of the nearly 3,000 foreign drug manufacturing facilities. America relies on these facilities for most of our prescription drugs.